David R. Haynes

7.9k total citations
117 papers, 6.4k citations indexed

About

David R. Haynes is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, David R. Haynes has authored 117 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 36 papers in Surgery and 28 papers in Rheumatology. Recurrent topics in David R. Haynes's work include Bone Metabolism and Diseases (45 papers), Orthopaedic implants and arthroplasty (34 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). David R. Haynes is often cited by papers focused on Bone Metabolism and Diseases (45 papers), Orthopaedic implants and arthroplasty (34 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). David R. Haynes collaborates with scholars based in Australia, United States and United Kingdom. David R. Haynes's co-authors include P. Mark Bartold, Donald W. Howie, Tania N. Crotti, David M. Findlay, Melissa Cantley, Gerald J. Atkins, Mark J. Pearcy, Susan Rogers, Shelley Hay and C.A. Holding and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

David R. Haynes

117 papers receiving 6.2k citations

Peers

Countries citing papers authored by David R. Haynes

Since Specialization

Citations

This map shows the geographic impact of David R. Haynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Haynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Haynes more than expected).

Fields of papers citing papers by David R. Haynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Haynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Haynes. The network helps show where David R. Haynes may publish in the future.

Co-authorship network of co-authors of David R. Haynes

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Haynes. A scholar is included among the top collaborators of David R. Haynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Haynes. David R. Haynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histone deacetylases (HDAC) in physiological and pathological bone remodelling 2016 ·Bone ·Melissa Cantley, Andrew C.W. Zannettino, P. Mark Bartold, David P. Fairlie, David R. Haynes	41
2	Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management 2013 ·Inflammopharmacology ·Donald W. Howie, Susan D. Neale, David R. Haynes, Oksana T. Holubowycz, Margaret A. McGee, Lucian B. Solomon, Stuart A. Callary, Gerald J. Atkins, David M. Findlay	34
3	Targeting Histone Deacetylase 1 (Hdac 1) to Suppress Both Inflammation and Bone Loss in Arthritis 2013 ·Internal Medicine Journal ·Melissa Cantley, David P. Fairlie, P. Mark Bartold, (unknown), Praveer Gupta, David R. Haynes	6
4	Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation 2012 ·Biochemical and Biophysical Research Communications ·(unknown), Anak A. S. S. K. Dharmapatni, Melissa Cantley, Kevin P. McHugh, David R. Haynes, Tania N. Crotti	22
5	Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro 2011 ·Journal of Cellular Physiology ·Melissa Cantley, David P. Fairlie, P. Mark Bartold, K. D. Rainsford, (unknown), Andrew J. Lucke, C.A. Holding, David R. Haynes	65
6	Low dose metal particles can induce monocyte/macrophage survival 2009 ·Journal of Orthopaedic Research® ·Derek Lacey, (unknown), Felix I. L. Clanchy, Mark Bailey, (unknown), David R. Haynes, Stephen E. Graves, John A. Hamilton	12
7	The use of live‐animal micro‐computed tomography to determine the effect of a novel phospholipase A₂ inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis 2009 ·Journal of Periodontal Research ·Melissa Cantley, P. Mark Bartold, V. Marino, Robert C. Reid, David P. Fairlie, (unknown), Peter Zilm, David R. Haynes	22
8	The Biologic Response to Particles From a Potential Disc Prosthesis Material 2008 ·Spine ·(unknown), C.A. Holding, David R. Haynes, B. Vernon‐Roberts, Peter Blumbergs, Robert D. Fraser, Robert J. Moore	3
9	Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor 2005 ·Journal of Cellular Physiology ·Andrew C.W. Zannettino, C.A. Holding, Peter Diamond, Gerald J. Atkins, P. Kostakis, (unknown), Jennifer R. Gamble, Luen Bik To, David M. Findlay, David R. Haynes	136
10	Receptor activator NF κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis 2003 ·Journal of Periodontal Research ·Tania N. Crotti, Malcolm Smith, Robert S. Hirsch, (unknown), Helen Weedon, (unknown), Michael Ahern, David R. Haynes	229
11	Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint 2001 ·Lara D. Veeken ·David R. Haynes, Tania N. Crotti, M Loric, Gretchen Bain, Gerald J. Atkins, David M. Findlay	172
12	The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis 2001 ·Journal of Bone and Joint Surgery - British Volume ·David R. Haynes, Tania N. Crotti, (unknown), M Loric, Gerald J. Atkins, Donald W. Howie, David M. Findlay	139
13	Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors 2000 ·Journal of Bone and Mineral Research ·Gerald J. Atkins, David R. Haynes, Stephen E. Graves, Andreas Evdokiou, Shelley Hay, Stelios Bouralexis, David M. Findlay	158
14	The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro 2000 ·The Journal of Arthroplasty ·Susan D. Neale, David R. Haynes, Donald W. Howie, David W. Murray, Nicholas A. Athanasou	52
15	Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist 2000 ·Biochemical Pharmacology ·David R. Haynes, Damien G. Harkin, Leon P. Bignold, (unknown), Stephen M. Taylor, David P. Fairlie	51
16	Implant Retrieval Studies of the Wear and Loosening of Prosthetic Joints 1998 ·Margaret A. McGee, Donald W. Howie, Kerry Costi, David R. Haynes, (unknown), Mark J. Pearcy, (unknown)	3
17	In Vitro Human Monocyte Response To Wear Particles Of Titanium Alloy Containing Vanadium Or Niobium 1997 ·Journal of Bone and Joint Surgery - British Volume ·(unknown), Donald W. Howie, Stephen E. Graves, Mark J. Pearcy, David R. Haynes	125
18	Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: The regulation of lymph node cell populations and cytokine production 1996 ·Inflammation Research ·David R. Haynes, S. J. Gadd, M. W. Whitehouse, Graham Mayrhofer, B. Vernon‐Roberts	14
19	Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin 1992 ·Biological Trace Element Research ·A M Rofe, Jeffrey C. Philcox, David R. Haynes, M. W. Whitehouse, Peter Coyle	21
20	Influence of Rat Strain and Arthritogen on Actions of Gold Drugs in Adjuvant-Induced Polyarthritis 1984 ·Annals of the Rheumatic Diseases ·B. Vernon‐Roberts, I. Ross Garrett, M. W. Whitehouse, Peter Brooks, David R. Haynes	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact